AU1764200A - Three dimensional structure of a sterile alpha motif domain - Google Patents

Three dimensional structure of a sterile alpha motif domain

Info

Publication number
AU1764200A
AU1764200A AU17642/00A AU1764200A AU1764200A AU 1764200 A AU1764200 A AU 1764200A AU 17642/00 A AU17642/00 A AU 17642/00A AU 1764200 A AU1764200 A AU 1764200A AU 1764200 A AU1764200 A AU 1764200A
Authority
AU
Australia
Prior art keywords
dimensional structure
sterile alpha
alpha motif
motif domain
domain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU17642/00A
Inventor
Frank Sicheri
David Stapleton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mount Sinai Hospital Corp
Original Assignee
Mount Sinai Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mount Sinai Hospital Corp filed Critical Mount Sinai Hospital Corp
Publication of AU1764200A publication Critical patent/AU1764200A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
AU17642/00A 1998-12-18 1999-12-17 Three dimensional structure of a sterile alpha motif domain Abandoned AU1764200A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11292998P 1998-12-18 1998-12-18
US60112929 1998-12-18
PCT/CA1999/001209 WO2000037500A1 (en) 1998-12-18 1999-12-17 Three dimensional structure of a sterile alpha motif domain

Publications (1)

Publication Number Publication Date
AU1764200A true AU1764200A (en) 2000-07-12

Family

ID=22346604

Family Applications (1)

Application Number Title Priority Date Filing Date
AU17642/00A Abandoned AU1764200A (en) 1998-12-18 1999-12-17 Three dimensional structure of a sterile alpha motif domain

Country Status (4)

Country Link
EP (1) EP1141016A1 (en)
AU (1) AU1764200A (en)
CA (1) CA2355163A1 (en)
WO (1) WO2000037500A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6927203B1 (en) 1999-08-17 2005-08-09 Purdue Research Foundation Treatment of metastatic disease
US7192698B1 (en) 1999-08-17 2007-03-20 Purdue Research Foundation EphA2 as a diagnostic target for metastatic cancer
US7101976B1 (en) 2000-09-12 2006-09-05 Purdue Research Foundation EphA2 monoclonal antibodies and methods of making and using same
EP1852441B1 (en) * 2002-09-24 2012-03-28 The Burnham Institute Agents that modulate EPH receptor activity
US8461119B2 (en) 2002-09-24 2013-06-11 The Burnham Institute Agents that modulate Eph receptor activity
KR20070118230A (en) 2005-01-27 2007-12-14 더 번햄 인스티튜트 Ephb receptor-binding peptides
CN109637596B (en) * 2018-12-18 2023-05-16 广州市爱菩新医药科技有限公司 Drug target prediction method

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE190226T1 (en) * 1991-12-02 2000-03-15 Univ Texas COMPOSITIONS FOR TRIGGERING CYTOTOXIC T-LYMPHOCYTES AGAINST VIRUSES
AU691915B2 (en) * 1994-04-04 1998-05-28 Regeneron Pharmaceuticals, Inc. Biologically active EPH family ligands
WO1996040189A1 (en) * 1995-06-07 1996-12-19 Glaxo Group Limited Peptides and compounds that bind to a receptor
EP1019728A1 (en) * 1995-10-13 2000-07-19 Mount Sinai Hospital Method of activating a novel ligand regulatory pathway
US5866343A (en) * 1997-04-15 1999-02-02 Universite De Montreal Energetically favorable binding site determination between two molecules

Also Published As

Publication number Publication date
WO2000037500A1 (en) 2000-06-29
EP1141016A1 (en) 2001-10-10
CA2355163A1 (en) 2000-06-29

Similar Documents

Publication Publication Date Title
AU7143998A (en) Surgical instrument
AU7144998A (en) Surgical instrument
AU7252098A (en) Surgical instrument
AU2332699A (en) Surgical instrument
AU7145098A (en) Surgical instrument
AU3549899A (en) Object-based anti-aliasing
AU1653901A (en) Organization of information technology functions
AU2070801A (en) Improved photoplethysmographic instrument
AU2746001A (en) Fast indexing of web objects
AU2926300A (en) Musical instrument
AU1303999A (en) Bathing implement
AU5531599A (en) Novel cdk inhibitors having flavone structure
AU2381400A (en) Bathing implement
AU5055899A (en) Capacitive position transducer
AU1025699A (en) Bathing implement
AU4117400A (en) Medical instruments
AU1764200A (en) Three dimensional structure of a sterile alpha motif domain
AU5394300A (en) Tissue engineering
AU1323900A (en) Handchime instrument
AU1112099A (en) Tissue removal
AU3301400A (en) Monosulphates of 4 or 6 disaccharides
AU3530499A (en) Writing instrument
AU6552300A (en) Medical instrument
AU5927900A (en) Alpha protein - 27
AUPP410798A0 (en) Towel

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase